CS logo
small CS logo
Advanced Neurosciences Institute

Franklin, Tennessee, United States
Neurologist in Franklin, Tennessee
101 Forrest Crossing Blvd, Franklin, TN 37064

About Advanced Neurosciences Institute


"Samuel F. Hunter, MD, PhD, is a neurologist and neuroimaging specialist based in Franklin, TN. An internationally renowned expert in multiple sclerosis & demyelinating diseases, Dr. Hunter has over 27 years of experience specializing in diagnoses and treatment of diseases including impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels relating to these structures. Advanced Neurosciences Institute is a regional neurological treatment center serving patients throughout the Southeastern United States established in 1997. It is Tennessee’s first subspecialty trained facility focused on MS. ANI provides advanced imaging, diagnostic services, & medical research technology."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Advanced Neurosciences Institute


During the past decade, Advanced Neurosciences Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100004422000000Started TrialsCompleted Trails20172018201920200246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®
2005-08-01
2006-02-01
Completed
50
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
2006-05-01
2011-07-01
Completed
1,292
Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
2006-06-01
2011-08-01
Completed
1,083
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
2007-08-01
2011-04-01
Completed
581
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
2007-10-01
2011-09-01
Completed
840
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
2009-08-01
2016-02-01
Completed
1,314
A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
2010-09-01
2015-02-01
Completed
65
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
2011-09-08
2013-09-26
Completed
209

Rows per page:

1–17 of 17

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Advanced Neurosciences Institute" #1 sponsor was "Genzyme, a Sanofi Company" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Novartis" with 2 trials sponsored, "Acorda Therapeutics" with 1 trials sponsored and "Actelion" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Neurosciences Institute" #1 collaborator was "Bayer" with 3 trials as a collaborator, "Immune Tolerance Network (ITN)" with 1 trials as a collaborator and "Novel Pharmaceutics Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGenzyme, a Sanofi Company: 3Genzyme, a Sanofi Company: 3Hoffmann-La Roche: 2Hoffmann-La Roche: 2Novartis: 2Novartis: 2Acorda Therapeutics: 1Acorda Therapeutics: 1Actelion: 1Actelion: 1AdvancedNeurosciences Institute:1AdvancedNeurosciences Institute:1Anokion SA: 1Anokion SA: 1Avanir Pharmaceuticals: 1Avanir Pharmaceuticals: 1Celgene: 1Celgene: 1Genentech, Inc.: 1Genentech, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsBayer: 3Bayer: 3Immune ToleranceNetwork (ITN): 1Immune ToleranceNetwork (ITN): 1Novel Pharmaceutics Institute: 1Novel Pharmaceutics Institute: 1

Clinical Trials Conditions at Advanced Neurosciences Institute


According to Clinical.Site data, the most researched conditions in "Advanced Neurosciences Institute" are "Multiple Sclerosis" (11 trials), "Multiple Sclerosis, Relapsing-Remitting" (4 trials), "Central Neuropathic Pain" (1 trials), "Hypogammaglobulinemia" (1 trials) and "Immunodeficiency" (1 trials). Many other conditions were trialed in "Advanced Neurosciences Institute" in a lesser frequency.

Clinical Trials Intervention Types at Advanced Neurosciences Institute


Most popular intervention types in "Advanced Neurosciences Institute" are "Drug" (13 trials), "Biological" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Interferon beta-1a" (3 trials), "Ocrelizumab" (3 trials), "Alemtuzumab" (2 trials) and "ANK-700" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Advanced Neurosciences Institute


The vast majority of trials in "Advanced Neurosciences Institute" are 17 trials for "All" genders.

Clinical Trials Status at Advanced Neurosciences Institute


Currently, there are NaN active trials in "Advanced Neurosciences Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Advanced Neurosciences Institute, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Advanced Neurosciences Institute, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 10Phase 3: 10Phase 1: 2Phase 1: 2Phase 2: 2Phase 2: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Active, not recruiting: 2Active, not recruiting: 2Recruiting: 2Recruiting: 2Unknown status: 2Unknown status: 2No longer available: 1No longer available: 1

Departments of Advanced Neurosciences Institute


Advanced Neurosciences Institute has several departments that took part in Clinical trials: "Advanced Neuroscience Center-Site Number:8400035" - 3 trials
Departments List
Total Rows: 1